SAMBATARO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.001
AS - Asia 1.117
SA - Sud America 521
EU - Europa 258
AF - Africa 25
OC - Oceania 1
Totale 3.923
Nazione #
US - Stati Uniti d'America 1.947
SG - Singapore 500
BR - Brasile 443
HK - Hong Kong 342
VN - Vietnam 118
IE - Irlanda 81
TR - Turchia 42
IT - Italia 41
GB - Regno Unito 32
DE - Germania 30
AR - Argentina 28
CA - Canada 22
BD - Bangladesh 18
MX - Messico 18
ID - Indonesia 17
IN - India 16
EC - Ecuador 14
RU - Federazione Russa 13
CN - Cina 12
CO - Colombia 11
JP - Giappone 11
ES - Italia 10
FR - Francia 8
IQ - Iraq 8
NL - Olanda 8
PY - Paraguay 8
ZA - Sudafrica 8
PL - Polonia 7
UA - Ucraina 7
AT - Austria 6
EG - Egitto 6
VE - Venezuela 6
MA - Marocco 5
PE - Perù 5
SE - Svezia 5
PK - Pakistan 4
QA - Qatar 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
HN - Honduras 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
FI - Finlandia 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
RS - Serbia 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
SV - El Salvador 1
TN - Tunisia 1
Totale 3.923
Città #
Dallas 1.398
Hong Kong 342
Singapore 223
Santa Clara 123
The Dalles 95
Dublin 81
Ashburn 76
Ho Chi Minh City 47
Istanbul 34
São Paulo 30
Hanoi 21
New York 21
Assago 20
Los Angeles 19
Rio de Janeiro 16
Belo Horizonte 10
Montreal 10
San Francisco 10
Tokyo 10
Düsseldorf 9
Mexico City 9
Brasília 8
Porto Alegre 8
Biên Hòa 7
Brooklyn 7
Curitiba 7
Manchester 7
Seattle 6
Thái Bình 6
Toronto 6
Warsaw 6
Atlanta 5
Denver 5
Dhaka 5
Frankfurt am Main 5
Guayaquil 5
Johannesburg 5
Lima 5
Limeira 5
London 5
Maceió 5
Manaus 5
Nova Iguaçu 5
Ankara 4
Asunción 4
Boston 4
Camaçari 4
Campinas 4
Catania 4
Caxias do Sul 4
Charlotte 4
Doha 4
Fortaleza 4
Lauterbourg 4
Phoenix 4
Santo André 4
Stockholm 4
São Bernardo do Campo 4
Araraquara 3
Bogotá 3
Cariacica 3
Chennai 3
Chicago 3
Cuiabá 3
Da Nang 3
Franca 3
Hải Dương 3
Jakarta 3
Joinville 3
Medellín 3
Mogi das Cruzes 3
Montevideo 3
Moscow 3
Osasco 3
Portsmouth 3
Ribeirão Preto 3
Rio Grande 3
Salvador 3
Tashkent 3
Thái Nguyên 3
Vienna 3
Addis Ababa 2
Amman 2
Anápolis 2
Aracaju 2
Arroio Grande 2
Baghdad 2
Barra Mansa 2
Belém 2
Blumenau 2
Buenos Aires 2
Bắc Ninh 2
Cachoeirinha 2
Cairo 2
Can Tho 2
Capão da Canoa 2
Caracas 2
Casablanca 2
Chaguanas 2
Cincinnati 2
Totale 2.899
Nome #
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 69
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 67
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 67
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project 54
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 50
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 49
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 49
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 48
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 48
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 47
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 47
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 46
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 46
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 45
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group 45
Autoimmunity in interstitial lung disease 45
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 44
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 44
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study 44
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply 44
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 43
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 43
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 43
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project 42
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 42
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 42
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 41
Pulmonary vasculitides: A radiological review emphasizing parenchymal hrct features 41
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 41
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 41
A die-hard giant capillary 40
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 40
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 39
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 39
COVAD survey 2 long-term outcomes: unmet need and protocol 38
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 38
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 38
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 38
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 37
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course 36
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey 36
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 35
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 35
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 34
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 34
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 34
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 34
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 34
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 34
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 33
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 33
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 33
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 32
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 32
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 32
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 32
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 31
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 31
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 30
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? 30
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes 30
Quantitative evaluation of fibrosis in ipf patients: Meaning of diffuse pulmonary ossification 30
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 30
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 30
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 29
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 28
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: Results from the COVAD study 28
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 27
Developing PI3K Inhibitors for Respiratory Diseases 27
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 27
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 27
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 26
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 26
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: A comparative analysis of the COVAD surveys 26
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 26
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 26
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 26
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 26
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives 26
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 26
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 26
Hepatic PPARs: Their role in liver physiology, fibrosis and treatment 25
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 25
Eosinophilic Interstitial Pneumonia 25
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 25
COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19 25
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 25
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 25
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 24
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 24
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 24
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 24
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 24
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys 24
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 24
Comorbidities of IPF: How do they impact on prognosis 24
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 24
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 24
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 24
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 24
Totale 3.495
Categoria #
all - tutte 22.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.523 0 0 0 0 334 287 113 127 156 189 203 114
2025/20262.549 214 941 719 553 69 53 0 0 0 0 0 0
Totale 4.072